National Comprehensive Cancer Network

|
|
|
|
For Patients

About NCCN

Central Nervous System Cancers Panel

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Philip J. Bierman, MD

Bradmer Pharmaceuticals

None

None

None

9/18/2009

Peter McLaren Black, MD, PhD

None

None

None

None

11/9/2009

Henry Brem, MD

None

None

None

None

11/5/2009

Steven Brem, MD

Northwest Biotherapeutics, Inc.;
Aisai Pharmaceutical

Genentech, Inc.;
Northwest Biotherapeutics, Inc.;
Aisai Pharmaceutical

None

None

7/6/2009

Nicholas Butowski, MD

None

None

None

None

9/11/2009

Marc C. Chamberlain, MD

NCCN Funded Bendamustine trial for Recurrent High-Grade Gliomas

Enzon Pharmaceuticals;
Genentech, Inc.;
Schering-Plough Corporation

None

None

11/12/2009

E. Antonio Chiocca, MD, PhD

None

None

None

None

12/15/2008

Lisa M. DeAngelis, MD

None

None

None

None

12/15/2008

Robert A. Fenstermaker, MD

None

None

None

None

11/13/2009

Allan Friedman, MD

None

None

None

None

1/2/2009

Lauren Gallagher, PhD

None

None

None

None

8/28/2009

Mark R Gilbert, MD

RTOG Trial

Genentech, Inc.;
Pfizer Inc.;
Schering-Plough Corporation

None

None

11/9/2009

Kristina M Gregory, RN, MSN, OCN

None

None

None

None

8/21/2009

Amy B Heimberger, MD

Celldex Therapeutics

Celldex Therapeutics

Celldex Therapeutics

None

7/1/2009

Deneen Hesser, MHSA, RN, OCN

None

None

None

Genentech, Inc.;
Takeda Pharmaceuticals North America, Inc.

11/10/2009

Maria Ho, PhD

None

None

None

None

7/1/2009

Larry Junck, MD

Genentech, Inc.

Genentech, Inc.

None

None

11/16/2009

Gerald P. Linette, MD, PhD

None

None

None

None

9/28/2009

Jay S. Loeffler, MD

None

Genentech, Inc.;
ProCure;
TransMolecular

None

None

7/21/2009

Moshe H Maor, MD

None

None

None

None

8/4/2009

Joan S McClure, MS

None

None

None

None

9/28/2009

Nicole McMillian, MS

None

None

None

None

7/21/2009

Paul L. Moots, MD

ECOG;
EMD Sereno

None

None

None

11/16/2009

Tara Morrison, MD, FRCPC

None

Genentech, Inc.

None

None

9/25/2009

Maciej M. Mrugala, MD, PhD, MPH

None

Enzon Pharmaceuticals;
Schering-Plough Corporation

None

None

11/16/2009

Louis Burt Nabors, MD

AstraZeneca Pharmaceuticals LP;
Genentech, Inc.;
Merck & Co., Inc.;
Transmolecular

Bayer HealthCare

None

None

7/28/2009

Herbert B. Newton, MD

None

Eisai Inc.;
UCB Pharma;
Schering-Plough Corporation

None

None

9/28/2009

Jana Portnow, MD

None

None

None

None

9/24/2009

Jeffrey J. Raizer, MD

Eli Lilly and Company;
Genentech, Inc.;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Vion

Enzon Pharmaceuticals;
Genentech, Inc.;
Schering-Plough Corporation

None

None

7/1/2009

Lawrence Recht, MD

Genentech, Inc.;
Schering-Plough Corporation

Genentech, Inc.

None

None

11/9/2009

Dennis C. Shrieve, MD, PhD

None

None

None

None

9/28/2009

Allen K. Sills, MD

Eisai Inc.

None

None

None

11/9/2009

Frank D. Vrionis, MD, MPH, PhD

None

None

None

None

11/16/2009

 

NCCN Website Supporters

Privacy Policy| Disclaimer| Site Map| Contact Us| Help| Copyright 2009